tiprankstipranks
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO
US Market

Spero Therapeutics (SPRO) Income Statement

Compare
519 Followers

Spero Therapeutics Income Statement

Last quarter (Q3 2024), Spero Therapeutics's total revenue was $7.82M, a decrease of -69.30% from the same quarter last year. In Q3, Spero Therapeutics's net income was $-17.73M. See Spero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 96.73M$ 48.58M$ 18.26M$ 9.33M$ 4.74M
Gross Profit
$ 96.37M$ 47.03M$ 17.14M$ -57.67M$ -61.03M
Operating Expenses
$ 75.25M$ 79.15M$ 106.23M$ 88.44M$ 67.96M
Depreciation and Amortization
$ 367.00K$ 1.55M$ 1.12M$ 1.35M$ 1.16M
EBITDA
$ 25.77M$ -42.26M$ -87.17M$ -76.93M$ -62.47M
Operating Income
$ 21.48M$ -42.20M$ -87.97M$ -79.11M$ -63.22M
Other Income/Expenses
$ 3.92M$ -4.22M$ -1.78M$ 833.00K$ 2.29M
Pretax Income
$ 25.40M$ -46.41M$ -89.76M$ -78.28M$ -60.92M
Net Income
$ 22.81M$ -48.03M$ -91.30M$ -77.52M$ -60.17M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.43$ -1.28$ -2.96$ -3.46$ -3.31
Diluted EPS
$ 0.43$ -1.28$ -2.96$ -3.46$ -3.31
Weighted Average Shares Outstanding
52.70M 37.59M 30.90M 22.39M 18.16M
Weighted Average Shares Outstanding (Diluted)
52.99M 37.59M 30.90M 22.39M 18.16M
Currency in USD

Spero Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis